BioNTech strikes $950mn deal for Chinese drugmaker Biotheus

BioNTech strikes $950mn deal for Chinese drugmaker Biotheus

FT.com

Published

Acquisition is latest example of western drugmakers turning to China to tap innovation

Full Article